AbbVie Receivables 2010-2024 | ABBV

AbbVie receivables for the quarter ending June 30, 2024 were $11.724B, a 2.03% increase year-over-year.

  • AbbVie receivables for 2023 were $11.155B, a 0.88% decline from 2022.
  • AbbVie receivables for 2022 were $11.254B, a 12.8% increase from 2021.
  • AbbVie receivables for 2021 were $9.977B, a 13.09% increase from 2020.

AbbVie Receivables 2010-2024 | ABBV

  • AbbVie receivables for 2023 were $11.155B, a 0.88% decline from 2022.
  • AbbVie receivables for 2022 were $11.254B, a 12.8% increase from 2021.
  • AbbVie receivables for 2021 were $9.977B, a 13.09% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Johnson & Johnson (JNJ)$450.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M